Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 210493

Expand all

AKYNZEO (FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE)
EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL
Marketing Status: Prescription
Active Ingredient: FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE
Proprietary Name: AKYNZEO
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N210493
Product Number: 001
Approval Date: Apr 19, 2018
Applicant Holder Full Name: HELSINN HEALTHCARE SA
Marketing Status:  Prescription
Patent and Exclusivity Information
AKYNZEO (FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE)
EQ 235MG BASE/20ML (EQ 11.75MG BASE/ML);EQ 0.25MG BASE/20ML (EQ 0.0125MG BASE/ML)
Marketing Status: Prescription
Active Ingredient: FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE
Proprietary Name: AKYNZEO
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: EQ 235MG BASE/20ML (EQ 11.75MG BASE/ML);EQ 0.25MG BASE/20ML (EQ 0.0125MG BASE/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N210493
Product Number: 002
Approval Date: May 27, 2020
Applicant Holder Full Name: HELSINN HEALTHCARE SA
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English